Overview

Utilization of Hepatitis C Positive Kidneys in Negative Recipients

Status:
Completed
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and feasibility of transplanting kidneys from Hepatitis C virus (HCV) infected donors into recipients without HCV infection
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ohio State University
Treatments:
Sofosbuvir
Sofosbuvir-velpatasvir drug combination
Velpatasvir